How we got to the Women's Health Initiative hormone replacement trial.

نویسنده

  • Joseph C Gambone
چکیده

Gambone • How we got to the Women’s Health Initiative trial A menopause, defined as the last menstrual period, is an integral and normal physiologic event in a woman’s life, it represents a sudden and dramatic change in reproductive capability, health risks, and self-image. The perimenopause (the 3 to 5 years before and after menopause) is characterized by symptoms of estrogen deficiency, such as hot flashes, mood swings, insomnia, and difficulty concentrating. The postmenopausal period is associated with increases in more serious health risks, including osteoporosis, cancer, and cardiovascular disease. As with many women’s health issues, however, menopause traditionally has been poorly understood. Although publications as early as the sixth century noted the characteristic onset of menopause during a woman’s middle age,1 philosophic explorations frequently lacked such simple acumen. As recently as the latter half of the 20th century, authors set menopause in stark terms. In the popular book Feminine Forever,2 Wilson described menopause as “the death of womanhood.” Menopause, he said, often destroyed a woman’s “character as well as her health”

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Perspectives on the women's health initiative trial of hormone replacement therapy.

The premature termination of one comparison in the Women's Health Initiative primary prevention trial due to stopping rules being reached necessitates a reconsideration of hormone replacement therapy (HRT). This part of the Women's Health Initiative trial, however, examined only one popular HRT regimen (conjugated equine estrogen [0.625 mg] and medroxyprogesterone acetate [2.5 mg] daily) in asy...

متن کامل

Health information seeking in context: how women make decisions regarding hormone replacement therapy.

This multimethod study explored women's information seeking behaviour and decision making regarding menopause, hormone replacement therapy (HRT), and use of complementary and alternative medicines (CAM) during menopause. This research was underway during the mass media release of the Women's Health Initiative (WHI) estrogen-progestin trial results, allowing an examination of the impact of this ...

متن کامل

Hormone replacement therapy and stroke: clinical trials review.

Bench research suggests that postmenopausal hormonal therapy is associated with beneficial effects on the brain and vascular system. Observational data suggest that postmenopausal hormone replacement therapy is associated with a 25% to 50% lower rate of cardiovascular disease; however, observational data for hormonal therapy is associated with the potential for significant biases. Clinical tria...

متن کامل

An Update on Hormone Replacement Therapy

The Department of Obstetrics, Gynecology, and Reproductive Sciences at the Yale School of Medicine hosted a daylong continuing medical education (CME) symposium titled "Health and Medicine for Women: A Multidisciplinary, Evidence-Based Review of Mid-Life Health Concerns" in September 2010. A number of speakers discussed current research on hormone replacement therapy (HRT) and re-evaluated the ...

متن کامل

New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.

Controversies about the safety of different postmenopausal hormone therapies (HTs) started 30 years ago and reached a peak in 2003 after the publication of the results from the Women Health Initiative (WHI) trial and the Million Women Study (MWS) [Writing group for the women's health initiative investigations. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • The Journal of the American Osteopathic Association

دوره 103 2 Suppl 2  شماره 

صفحات  -

تاریخ انتشار 2003